Ongoing Clinical Trials Ongoing Clinical Trials

Ongoing Clinical Trials

Home >> Clinical Trial Guidance >> Ongoing Clinical Trials

We inform you of the clinical trials that are being conducted by K-MASTER Precision Medicine Project Group.

* Protocol No. KM-10(A)
* Research Title Phase II Study of Trastuzumab plus Gedatolisib in Patients with HER-2 Positive Metastatic Breast Cancer Who Progressed after 2 or more HER-2 directed Chemotherapy
* Overall Research Director Park Kyung Hwa Affiliate Korea University Anam Hospital
Carcinoma HER-2 Benign metastatic breast cancer
Target Gene PIK3CA/Akt/PTEN Clinical Trial Drug Trastuzumab/Gedatolisib
Research period 2018.06.28 ~ 2021.12.31 Progress Status registering
Number of recipients 0 / 62 Registration rate 0%

Institutional research participation

No. Research manager Research institution

:: There is no registered research participant information. ::

prev list next

arrow Method of participation

If you want to participate in the clinical examination, please contact the email address below.

Email kmaster@korea.ac.kr | CONTACT Secretariat 02.2286.1564 | Clinical Trial Coordinating Center 02.2286.1562